TTY Biopharm Co Ltd (4105): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 77,5 Dollar (TWD) | 87 Dollar (TWD) | 71,6 Dollar (TWD) |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 92 Dollar (TWD) | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 248.649.959 | - | - |
Kennzahl in 1000 TWD | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 6.452.948 | 5.893.847 | 5.505.542 | 5.061.606 | 4.535.610 | 4.221.836 | 4.466.308 | 4.036.196 | 4.078.760 |
Cashflow aus operativer Geschäftstätigkeit | 1.761.837 | 1.349.376 | 1.085.313 | 1.235.759 | 1.256.341 | 526.351 | 1.209.855 | 1.073.798 | 996.520 |
▸ Operative Cashflow Marge | 27,3% | 22,89% | 19,71% | 24,41% | 27,7% | 12,47% | 27,09% | 26,6% | 24,43% |
Investitionsausgaben (CapEx) | 150.832 | 134.294 | 99.581 | 135.501 | 74.154 | 181.860 | 69.863 | 74.095 | 96.791 |
Cashflow aus Investitionstätigkeit | - | - | - | -133.136 | -168.779 | 147.236 | -273.150 | 1.696.399 | -730.067 |
Cashflow aus Finanzierungstätigkeit | - | - | -816.328 | -1.103.401 | -1.044.128 | -806.608 | -849.271 | -1.861.658 | -875.583 |
Freier Cashflow | 1.611.005 | 1.215.082 | 985.732 | 1.100.258 | 1.182.187 | 344.491 | 1.139.992 | 999.703 | 899.729 |
▸ Freie Cashflow Marge | 24,97% | 20,62% | 17,9% | 21,74% | 26,06% | 8,16% | 25,52% | 24,77% | 22,06% |
Ausgeschüttete Dividenden | -1.044.330 | -870.275 | -845.410 | -745.949 | -994.600 | -994.599 | -1.118.925 | -1.118.925 | -944.870 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.